News & Updates
Filter by Specialty:
Statin-ezetimibe combo superior to monotherapy in preventing CVD in T2D patients
In patients with type 2 diabetes (T2D), moderate-intensity statin in combination with ezetimibe results in greater reductions in low-density lipoprotein cholesterol (LDL-C) and better prevention of adverse outcomes when compared with high-intensity statin monotherapy, suggests a study.
Statin-ezetimibe combo superior to monotherapy in preventing CVD in T2D patients
27 Jun 2024
Use of mHealth more frequent in adults with high CVD risk
Mobile health (mHealth) technology appears advantageous among adults with a greater number of cardiovascular disease (CVD) risk factors, who use the technology to share information and discuss health-related decisions with their providers, according to a study.
Use of mHealth more frequent in adults with high CVD risk
22 Jun 2024
Two-component nutritional strategy on par with standard approach for BP control
A two-component nutritional strategy is as effective as the established dietary intervention for blood pressure (BP) control in individuals with hypertension, results of the NUPRESS study have shown.
Two-component nutritional strategy on par with standard approach for BP control
21 Jun 2024
Vaccine combo a promising therapy for hypertension
Combined treatment with ATRQβ-001 and ADRQβ-004 vaccines shows potential as a therapeutic strategy for hypertension management, according to the preliminary findings of a study.
